| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/11/2011 | US20110195950 Organic Compounds |
| 08/11/2011 | US20110195933 Pyrazolo[1,5-a]pyridines as mark inhibitors |
| 08/11/2011 | US20110195929 Compounds for the treatment of flaviviral infections |
| 08/11/2011 | US20110195408 Labeling Dye for Detecting Biomolecule, Labeling Kit, and Method for Detecting Biomolecule |
| 08/11/2011 | DE102010007059A1 Verfahren zur Herstellung von 3,7-Diaza-bicyclo[3.3.1]nonan-Metallkomplexen Process for the preparation of 3,7-diaza-bicyclo [3.3.1] nonane-metal complexes |
| 08/11/2011 | DE102010007058A1 Verfahren zur Herstellung von 3,7-Diaza-bicyclo[3.3.1]nonan-Metallkomplex-Lösungen Process for the preparation of 3,7-diaza-bicyclo [3.3.1] nonane-metal complex solutions |
| 08/11/2011 | CA2789021A1 Hetaryl-[1,8]naphthyridine derivatives |
| 08/11/2011 | CA2787360A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 08/10/2011 | EP2354141A1 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders. |
| 08/10/2011 | EP2354140A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 08/10/2011 | EP2354139A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 08/10/2011 | EP2352746A1 Bioactive compounds |
| 08/10/2011 | EP2352733A1 Benzonaphtyridine compounds used as inhibitors of autotaxin |
| 08/10/2011 | EP2352732A1 2, 5-diamino-substituted pyrido ý4, 3-d¨pyrimidines as autotaxin inhibitors against cancer |
| 08/10/2011 | EP2352731A1 Gamma secretase modulators |
| 08/10/2011 | EP2352730A2 Biologically active amides |
| 08/10/2011 | EP2352376A1 Spiroheterocyclic n-oxyamides as pesticides |
| 08/10/2011 | EP2352375A2 Herbicidal compositions |
| 08/10/2011 | CN1972940B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 08/10/2011 | CN1129942B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity |
| 08/10/2011 | CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/10/2011 | CN102149713A Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149712A Pyrazole [3, 4-b] pyridine Raf inhibitors |
| 08/10/2011 | CN102149706A Antineoplastic derivatives of 4-oxo-L,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149383A Pharmaceutical agent, food or beverage having inhibitory activity on serotonin transporter |
| 08/10/2011 | CN102146084A 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines |
| 08/10/2011 | CN102146080A Beta-carboline alkali derivative compounds and application thereof |
| 08/10/2011 | CN101619063B 3,7,8-polysubstituted pyridine-[4,3-d] pyrimidine derivant with antitumor activity and preparation |
| 08/10/2011 | CN101544634B 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof |
| 08/10/2011 | CN101497613B Preparation of praziquanamine |
| 08/10/2011 | CN101415702B Hetero compound |
| 08/10/2011 | CN101351466B Heterocyclic Janus kinase 3 inhibitors |
| 08/10/2011 | CN101302216B Preparation of condensed ring indole compounds |
| 08/10/2011 | CN101242832B Fused pyrazole as p38 MAP kinase inhibitors |
| 08/10/2011 | CN101014602B Monocyclic anilide spirolactam cgrp receptor antagonists |
| 08/09/2011 | US7994333 Methods and compositions for selectin inhibition |
| 08/09/2011 | US7994314 Method for the preparation of an enantiomerically pure benzazepine |
| 08/09/2011 | US7994202 Bicyclic nitrogen-containing heterocyclic compounds |
| 08/09/2011 | US7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 08/09/2011 | US7994196 Indazole compound and pharmaceutical use thereof |
| 08/09/2011 | US7994192 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 08/09/2011 | US7994187 HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones |
| 08/09/2011 | US7994173 2-piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivatives |
| 08/09/2011 | US7994170 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors |
| 08/09/2011 | US7994160 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 08/09/2011 | US7994156 Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/09/2011 | CA2665195C Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| 08/09/2011 | CA2551508C Novel quinoline derivatives |
| 08/09/2011 | CA2445190C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/04/2011 | WO2011094285A1 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | WO2011094283A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094273A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011093609A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/04/2011 | WO2011093501A1 Gpr119 agonist |
| 08/04/2011 | WO2011092469A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 08/04/2011 | WO2011092272A1 Gamma secretase modulaters |
| 08/04/2011 | WO2011092198A1 5-alkynyl-pyrimidines |
| 08/04/2011 | WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | WO2011092128A1 Substituted naphthyridines and their use as syk kinase inhibitors |
| 08/04/2011 | WO2011067356A3 Polymorphs of a mek inhibitor |
| 08/04/2011 | WO2011067348A3 Mek inhibitor salts and solvates thereof |
| 08/04/2011 | WO2010023561A9 Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof |
| 08/04/2011 | US20110190502 Process for the preparation of s-clopidogrel |
| 08/04/2011 | US20110190490 Oxazolopyrimidines as edg-1 receptor agonists |
| 08/04/2011 | US20110190489 Novel Tricyclic Compounds |
| 08/04/2011 | US20110190486 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 08/04/2011 | US20110190337 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 08/04/2011 | US20110190336 Azabenzimidazolones |
| 08/04/2011 | US20110190335 Nitrogenated 5-membered heterocyclic compound |
| 08/04/2011 | US20110190334 Heterocyclic Sulfonamide Derivatives |
| 08/04/2011 | US20110190329 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 08/04/2011 | US20110190326 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 08/04/2011 | US20110190311 Use of cdk inhibitor for the treatment of glioma |
| 08/04/2011 | US20110190310 Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators |
| 08/04/2011 | US20110190297 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190269 Gamma secretase modulators |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190257 Bicyclic heterocycles as mek kinase inhibitors |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110189174 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | US20110189089 Radiofluorination |
| 08/04/2011 | US20110186821 Azapyrenes for electronic applications |
| 08/04/2011 | CA2787407A1 5-alkynyl-pyrimidines |
| 08/04/2011 | CA2787396A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | CA2787321A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787315A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2786245A1 Substituted naphthyridines and their use as syk kinase inhibitors |
| 08/04/2011 | CA2780421A1 Gamma secretase modulaters |
| 08/03/2011 | EP2351795A1 Dye compound, process for producing same, and coloring agent |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351745A1 Pyrazine derivatives and use as PI3K inhibitors |
| 08/03/2011 | EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |